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Phich White Blood Cell Subtypes
redict Increased Cardiovascular Risk?
enjamin D. Horne, PHD, MPH,* Jeffrey L. Anderson, MD, FACC,*† Jerry M. John, MD,*†
aron Weaver, MD,*† Tami L. Bair, BS,* Kurt R. Jensen, MS,* Dale G. Renlund, MD, FACC,*†
oseph B. Muhlestein, MD, FACC,*† for the Intermountain Heart Collaborative (IHC) Study Group
alt Lake City, Utah
OBJECTIVES We sought to determine the predictive ability of total white blood cell (WBC) count and its
subtypes for risk of death or myocardial infarction (MI).
BACKGROUND An elevated WBC count has been associated with cardiovascular risk, but which leukocyte
subtypes carry this risk is uncertain.
METHODS Consecutive patients without acute MI who were assessed angiographically for coronary
artery disease (CAD) and were followed up long-term were studied. The predictive ability for
death/MI of quartile (Q) 4 versus Q1 total WBC, neutrophil (N), lymphocyte (L), and
monocyte (M) counts and N/L ratio were assessed using Cox regressions.
RESULTS A total of 3,227 patients was studied. Mean age was 63 years; 63% of patients were male, and
65% had CAD. In multivariable modeling entering standard risk factors, presentation, and
CAD severity, the total WBC (hazard ratio [HR] 1.4, p  0.01) and M (HR 1.3, p  0.02)
were weaker and N (HR 1.8, p  0.001), L (HR 0.51, p  0.001), and N/L ratio (HR 2.2,
p  0.001) were independent predictors of death/MI. When WBC variables were entered
together, N/L ratio and M were retained as independent predictors. Risk associations
persisted in analyses restricted to CAD patients or including acute MI patients.
CONCLUSIONS Total WBC count is confirmed to be an independent predictor of death/MI in patients with
or at high risk for CAD, but greater predictive ability is provided by high N (Q4 6.6 
103/l) or low L counts. The greatest risk prediction is given by the N/L ratio, with Q4 versus
Q1 (4.71 versus 1.96) increasing the hazard 2.2-fold. These findings have important
implications for CAD risk assessment. (J Am Coll Cardiol 2005;45:1638–43) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.054the American College of Cardiology Foundation
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wtherosclerosis is a multifactorial disease, with dyslipide-
ia, dysglycemia, smoking and other causes of endothelial
njury, and genetic predisposition all contributing to patho-
enesis (1,2). In recent years, it has been recognized that
therogenesis represents an active, inflammatory process
ather than simply passive injury with infiltration of lipids
1,3,4). Leukocytes play a major role in these inflammatory
rocesses (5), which may be either adaptive (reparative) or
aladaptive, and acute or chronic. Mononuclear cells
monocyte/macrophages, T-lymphocytes) are prevalent and
athogenic within unstable coronary artery plaques (1–3).
eutrophils are intimately involved with adaptive infarct
ealing, but also may be pathogenic (e.g., as with leukocyte-
latelet aggregate formation, and as a cause of reperfusion
njury in the setting of acute coronary syndromes) (6–8).
The circulating white blood cell (WBC) count has been
roposed as one of a few biomarkers of potential current
tility for cardiovascular risk prediction (9). Of these pro-
osed inflammatory markers, C-reactive protein (CRP) has
een the most extensively studied and clinically applied to
ate; however, its value as a predictor of risk has recently
From the *Cardiovascular Department, LDS Hospital, and the †University of
tah, Salt Lake City, Utah. Supported by the Deseret Foundation, Salt Lake City,
tah.q
Manuscript received December 7, 2004; revised manuscript received January 25,
005; accepted February 8, 2005.een questioned (10,11), and the need to develop and apply
dditional complementary inflammatory markers of risk is
pparent. The WBC count provides an assessment of
nflammatory status (5), but this inexpensive and universally
btained test result has not been fully explored or exploited
or its predictive ability (9).
A number of observational epidemiologic studies over
ore than a decade have noted a relationship between
BC count and the risk of symptomatic or fatal coronary
eart disease (CHD) (12–20). Further studies have linked
n elevated leukocyte count to increased short- and longer-
erm risk for ischemic events and death in patients present-
ng with acute coronary syndromes (21–24). Despite these
requent associations of total WBC count with cardiovas-
ular risk, controversy exists about the value of WBC count
ndependent of smoking and gender and the at-risk popu-
ations to which it applies. Moreover, little has been
ublished about the predictive ability of specific differential
BC counts to predict CHD risk.
The goal of this study was to further establish the
redictive ability of total WBC count for CHD, indepen-
ent of standard risk factors, and to explore the specific
uestion of which leukocyte subtypes (compartments) carry
his increased risk. The study was undertaken in a large
ohort of consecutive patients with or at high risk for CHD
ho underwent coronary angiography and were subse-
uently followed up long-term.
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tudy population. Study patients were drawn from the
ardiac catheterization registry of the Intermountain Heart
ollaborative Study, a population of patients undergoing
oronary arteriography at the LDS Hospital (Salt Lake
ity, Utah). Patients of unrestricted age and gender pro-
ided written informed consent for a blood draw at the time
f angiography for use in confidential studies approved by
he hospital’s institutional review board. Clinical presenta-
ion included a stable pattern of chest pain or other clinical
ndication for coronary angiography (i.e., stable angina,
ositive stress test result, and so on) or an unstable pattern
f chest pain (suggesting unstable angina). Patients with an
cute myocardial infarction (MI) during the index hospital-
zation were excluded from the primary analysis but were
ncluded in a secondary analysis.
Of consecutive angiographically studied patients enrolled
etween 1994 and 2001, 3,227 were found to have blood
ested at baseline (on admission, before angiography) for
otal and differential WBC count, did not present with
cute MI (i.e., did not have creatine kinase-myocardial band
CK-MB] 6 mg/dl or CK-MB index 3%), survived
ospitalization, had long-term follow-up, and were in-
luded in this study. Angiography was scheduled electively
or patients with a stable pattern of symptoms (e.g., stable
ngina) and was scheduled urgently at hospital admission
or those with unstable symptoms.
ollow-up and patient outcomes. Patients were followed
p until death or until December 2001. Deaths were
etermined from electronic hospital records, State of Utah
ealth Department records, and national Social Security
dministration death records. Patients not listed as de-
eased in any registry were considered to be alive. Incident
I (after the index hospitalization) was identified by
earching the Intermountain Health Care electronic medi-
al records database. In patients with a discharge diagnosis
f MI (International Classification of Diseases-9th Revision
ode), confirmation was further made by identifying a
Abbreviations and Acronyms
AUC  area under the curve
CAD  coronary artery disease
CHD  coronary heart disease
CI  confidence interval
CK-MB  creatine kinase-myocardial band
CRP  C-reactive protein
HR  hazard ratio
L  leukocyte
M  monocyte
MI  myocardial infarction
N  neutrophil
Q  quartile
WBC  white blood cellK-MB 6 mg/dl or a CK-MB index 3% (troponin was sot routinely measured in patients entered in the early years
f the database).
tudy variables. Total WBC count and peripheral differ-
ntial leukocyte count were assessed using standard Coulter
ounter techniques (Coulter Gen·S Hematology Analyzer,
eckman Coulter Corp, Hileh, Florida). The intra-assay
oefficient of variation for WBC was 2.5%, and the standard
rrors of neutrophil (N), lymphocyte (L), and monocyte
M) counts were 3.0%, 2.7%, and 2.7%, respectively. The N,
, and M counts were prospective variables of interest, and
he N/L ratio was tested post hoc.
ther variables examined. Risk factors, historical items,
nd physical findings were determined from the physician’s
eport on the demographics page of the LDS Hospital’s
tandard angiographic report form. Study variables other
han WBC included age, gender, diabetes, hypertension,
yperlipidemia, smoking, family history of early coronary
rtery disease (CAD), and number of severely diseased
oronary vessels (i.e., zero, one, two, or three coronary
rteries with 70% stenosis as determined at angiography
y the patient’s physician). Diabetes was determined by
hysician report and was based on a fasting blood sugar level
126 mg/dl or use of an antidiabetes medication. Hyper-
ension was physician-reported for systolic blood pressure
140 mm Hg, diastolic blood pressure90 mm Hg, or use
f anti hypertensive agents. Hyperlipidemia was physician-
eported for total cholesterol 200 mg/dl, low-density
ipoprotein level130 mg/dl, or use of cholesterol-lowering
edication. Family history was self-reported when a first-
rder relative had suffered cardiovascular death, MI, or
oronary revascularization before age 65. Smoking included
ctive or previous (10 pack-years) tobacco use. Clinical
resentation included stable angina (exertional symptoms
nly, including a positive stress test result) or unstable
ngina (progressive symptoms or symptoms at rest). Left
entricular ejection fraction was measured only among 74%
f patients, by ventriculography or echocardiogram, and was
ncluded in the secondary analysis as a categorical variable
or 40%, 40%, or missing.
tatistical considerations. Patient demographic character-
stics are presented as means and standard deviations for
ontinuous variables and as proportions (percentages) for
ategorical variables. Simple two-group comparisons used
hi-square for categorical and t-test statistics for continuous
ariables. Because WBC and differential counts were non-
ormally distributed, these variables are presented as geo-
etric mean with 25th and 75th percentile ranks and are
urther categorized into quartiles for the primary analyses.
atural logarithmic transformation was found to normalize
he distributions. All statistical comparisons of WBC and
ifferential counts used natural logarithmic-transformed
BC variables. Time-to-event analyses were performed
sing univariable and multivariable (forced entry or back-
ard stepwise conditional) Cox regression analysis. Condi-
ional entry into the regression model was based on the
tatus of a variable as a confounder of the WBC variables,
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White Blood Cells and Cardiovascular Risk May 17, 2005:1638–43nd its removal was based on the criterion of p  0.15 for
he covariate, whereas forced entry was used for variables
hat were independently significant or had a confounding
ffect (association of covariate with WBC variable and
10% change in regression coefficient). Because of multi-
olinearity, WBC count and its subcompartments were
ntered in different models. Colinearity diagnostics were
lso assessed between subcompartments. The primary end
oint was the first occurrence of MI or death after hospital
ischarge. Nominal significance was taken as a two-tailed p
alue 0.05.
ESULTS
tudy population. The study population consisted of
,227 angiographically studied high-risk patients (Table 1).
he mean age of the patients was 63 years; 63% were male,
0% were hypertensive, 42% were hyperlipidemic, 17% were
mokers, and 17% were diabetic; CAD was found to be
resent in 65%.
aseline WBC counts. Total and differential subtype
BC counts were nonnormally distributed. Baseline values
re presented as geometric means with 25th and 75th
ercentile ranks and as quartiles in Table 2.
nivariable prediction of death/MI. A total of 478
14.8%) patients died (N  294), had a nonfatal MI event
N  219), or both by the time of the last follow-up, which
veraged 3.5 years (Table 1). In univariable analysis, an
ncreased hazard ratio (HR) of death/MI was associated
able 2. Baseline White Blood Cell Counts
White Blood Cells/103/l
Geometric Mean
(25th, 50th, 75th Percentiles)
otal white blood cell count 7.82 (6.2, 7.6, 9.4)
eutrophils 5.15 (3.8, 5.0, 6.6)
onocytes 0.55 (0.4, 0.6, 0.7)
ymphocytes 1.56 (1.2, 1.7, 2.2)
able 1. Baseline Characteristics (Proportions [%], Averages
Mean  SD], or Medians)
Characteristic
Overall
(N 3,227)
No Event
(N 2,749)
Event
(N 478) p Value
ge (yrs) 63  14 61  14 69  13 0.001
ender (male) 63% 63% 63% 0.97
ypertension 50% 50% 49% 0.62
yperlipidemia 42% 44% 33% 0.001
iabetes 17% 16% 21% 0.001
moking 17% 18% 16% 0.36
amily history 31% 32% 24% 0.001
nstable angina 29% 31% 21% 0.001
iseased vessels
0 35% 36% 31%
1 23% 23% 26%
2 18% 18% 19%
3 23% 22% 24% 0.06
Statistical comparisons are from 2 degrees of freedom analysis of variance or 2 to 6
egrees of freedom Pearson chi square tests.(eutrophil/lymphocyte ratio 3.29 (1.96, 2.87, 4.71)ith the fourth (vs. first) quartile (Q) total WBC (HR 
.4, p  0.01), N (HR  2.1, p  0.001), and M counts
HR  1.4, p  0.01); reduced risk with L count (HR 
.41, p  0.001); and increased risk with N/L ratio (HR 
.7, p  0.001) (Fig. 1). Similarly, for absolute counts
natural log-transformed), an increased HR of death/MI
as found for total WBC (HR  1.42/ln unit, p  0.004),
(HR  1.69/ln unit, p  0.001), and M (trend) (HR 
.2/ln unit, p  0.053); reduced risk with L count (HR 
.59/ln unit, p  0.001); and increased risk with N/L ratio
HR  1.49/ln unit, p  0.001).
esults of multivariable analysis. In multivariable mod-
ling, entering an individual WBC variable, standard risk
actors, presentation, and CAD severity, WBC (HR  1.4,
 0.01) and M (HR  1.3, p  0.02) were weaker and
(HR  1.8, p  0.001), L (HR  0.51, p  0.001), and
/L ratio (HR  2.2, p  0.001) were stronger indepen-
ent predictors of death/MI (Fig. 1). When WBC variables
ere entered together, N/L ratio and M were retained as
ndependent predictors, together with age, diabetes, presen-
ation, CAD severity, and family history (Table 3). Adjust-
ent for ejection fraction caused only a minor change in
ffect size for N/L ratio (HR  2.1, p  0.001) and none
or M (HR 1.4, p 0.01). When further adjustment was
ade for treatment factors by forced entry of interventional
reatment (none, percutaneous coronary intervention, by-
ass surgery) and medical therapy (statin, beta-blocker,
onverting enzyme inhibitor), no diminution in the multi-
ariable prediction by N/L ratio (HR  2.4, 95% CI 1.8 to
.2, p  0.001) or monocyte count (HR  1.4, 95% CI 1.1
o 1.7, p  0.01) was observed.
The N/L ratio strongly predicted death alone or MI alone
s outcome variables. The multivariable HR for death of the
/L ratio was 3.0 (95% CI 2.1 to 4.3, p  0.001). The
4/1 N/L ratio also predicted an increased relative risk of
ncident MI alone, 1.6 (95% CI 1.1 to 2.4, p  0.026).
dditional analyses and incremental risk. Risk associa-
ions of WBC subtypes also were assessed in a more
estricted population limited to patients with significant
ngiographic CAD (70% stenosis, N  2,292) as well as
n expanded population that included patients in the an-
iographic database with a diagnosis of acute MI (N 
,625). Risk associations persisted in both of these analyses
Table 4). In an additional analysis, the N/L ratio also
redicted increased risk among high-risk patients free from
cclusive angiographic CAD (Table 4).
To address the question of incremental predictive ability of
BC parameters, the area under the curve (AUC) for risk
sing the standard independent risk factors (Table 3) was first
alculated: the AUC was 0.675. When the total WBC count
as added to this multivariable predictive model, the AUC
ncreased modestly to 0.689. When the N/L ratio and M
uartiles were substituted for total WBC count, the AUC
ncreased notably to 0.718 (p  0.001). This AUC increment
0.038) compares favorably to that obtained with high-
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isease [MONICA] study) (25).
ISCUSSION
ummary of study findings. The primary findings of this
tudy are that a simple, relatively inexpensive, almost uni-
ersally obtained test (the WBC count with differential)
ontains important risk information that is not only signif-
cant on its own but also is incremental to standard clinical
ardiovascular risk factors. Further, the study found that
reater predictive ability is contained within the WBC
ifferential than is represented by the total WBC count
lone. The incremental improvement in risk prediction
chieved with the WBC differential was similar to or greater
han that reported for the widely used inflammatory marker
igh-sensitivity CRP (25).
The predictive value of the WBC count has been re-
orted in other populations (12–20), but the optimization of
isk prediction by use of the WBC differential is a unique
ontribution of this study. We found that a relatively high N
ount, a relatively low L count, and, more modestly, an
levated M count account for WBC count risk. An elevated
able 3. Multivariable Model for Death/Myocardial Infarction
Variables
Hazard Ratio
(95% CI)
p
Value
eutrophil/lymphocyte ratio (Q4 vs. Q1) 2.2 (1.7–2.9) 0.001
onocytes (Q4 vs. Q1) 1.4 (1.1–1.6) 0.007
ge (per decade) 1.4 (1.3–1.5) 0.001
iabetes 1.5 (1.2–1.8) 0.001
oronary artery disease severity
(per number of diseased vessels)
1.2 (1.1–1.4) 0.001
nstable angina 0.77 (0.62–0.95) 0.01
amily history 0.83 (0.68–1.03) 0.09
Figure 1. Univariate (uv) and multivariate (mv) analysis of quartile 4pI  confidence interval; Q  quartile./L ratio, explored post hoc, proved to be the most
owerful single WBC count predictor, with Q4 ratios
4.7, or about 5 or more, for convenience) elevating risk
hree-fold, compared with Q1 ratios (2). The results were
obust: for even higher-risk populations consisting entirely
f patients with angiographic CAD, or for our full angio-
raphically studied population, including patients with
cute MI, the Q4 N/L ratio remained strongly predictive. A
ubstantial proportion of this WBC-subtype-related risk
ersisted in multivariable analyses. Given the routine acqui-
ition of WBC counts, it also can be argued that other
arkers of inflammation should be adjusted for WBC risk
nformation, rather than vice versa, when assessing incre-
ental predictive ability.
iterature comparisons. A number of epidemiologic ob-
ervational studies have reported an association between
levated WBC counts and symptomatic or fatal CHD
12–20). Additional studies in patients presenting with
cute coronary syndromes have linked elevated leukocyte
ount to increased short-term and longer-term risk for fatal
nd nonfatal ischemic events (21–24). Despite this, not
very study has found this association to be independent of
ther risk factors, such as smoking and gender (15,26).
urthermore, few have investigated which differential sub-
ype carries this risk (16,26–28). A French study found an
ncreased monocyte count to carry increased risk, whereas a
ritish and two Asian studies reported that high N counts
redicted greater risk (16,26,27). The WBC differential
dded to CK-MB determination in diagnosing acute MI in
ne study (29).
These studies were primarily in subjects at primary CHD
isk. Studies of differential WBC risk in higher-risk, non-
nfarct, primary and secondary CHD risk cohorts, and in
s 1 white blood cell (WBC) subtypes. N/L  neutrophil/leukocyte.atients evaluated and treated in a contemporary U.S. health
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White Blood Cells and Cardiovascular Risk May 17, 2005:1638–43are system have not been reported to our knowledge. Our
tudy addressed this gap and found that N count, and
specially N/L ratio, predicted increased risk.
echanistic considerations. It has been long known that
yocardial injury (acute MI) is followed by neutrophilia,
he early appearance of neutrophils within the infarct zone
ith heavy infiltration by 1 to 3 days, followed by infarct
ealing and replacement fibrosis. Recent human trials using
ntracoronary transfer of autologous bone marrow, rich in
ematopoietic and mesenchymal precursor cells, have sug-
ested a benefit after MI (30,31) and have postulated to
epresent augmentation of intrinsic reparative processes.
cute MI was excluded in our primary analysis, but neu-
rophilia also could mark an augmented, more chronic
daptive response to ischemia (e.g., vasculogenesis). Neu-
rophilia also might indicate maladaptive processes: circu-
ating leukocyte-platelet aggregates appear in acute coronary
yndromes and might facilitate vascular plugging and infarct
xtension (6,7,21,32). Reperfusion injury (8), occurring
pontaneously or after reperfusion therapy, has been postu-
ated to be leukocyte mediated, and trials of inhibitors of
eukocyte adhesion and transmigration have been under-
aken, albeit without clinical success to date (33,34).
That the cardiovascular risk of elevated WBC counts is
arried by increased circulating neutrophil counts and de-
reased total mononuclear cell counts (lymphocytes plus
onocytes) is not intuitively obvious. Indeed, atheroscle-
otic plaque is characterized by infiltrates of monocytes/
acrophages and lymphocytes, which have transmigrated
rom the vascular space into subendothelial layers of large
nd medium-sized arteries (3,4,35,36). If circulating WBC
ractions were to maintain equilibrium with plaque frac-
ions, then a parallel increase in absolute or proportionate
ononuclear cell counts at the expense of a polymorpho-
uclear cell count could be postulated. However, this is not
hat was observed: we found that relative neutrophilia
ogether with lymphopenia was associated with increased
ardiovascular risk.
These observations support evidence that neutrophils are
nvolved in ischemic cardiovascular disease, particularly its
cute phases. Increased expression of neutrophil and mono-
yte adhesion molecules and other markers (e.g., CD11b/
D18) of polymorphonuclear and monocyte activation in
he peripheral blood has been described in patients with
cute coronary syndromes and ischemic heart disease
Table 4. Univariable Results for Neutrophil/Ly
Three Secondary Interest Populations
Population # D-MI/Tota
All patients, except acute MI 478/3227
No CAD patients 96/935
CAD patients, no acute MI 382/2292
All patients, including MI 769/4625
CAD  coronary artery disease; D  death; MI  myocar37,38). Recently, neutrophil invasion of atherosclerotic
ilaque has been directly visualized in an animal model (39)
nd has been shown in the culprit clinical plaques in patients
ith acute coronary syndromes (40). Neutrophils can facil-
tate plaque disruption by releasing superoxide radicals,
roteolytic enzymes, and arachidonic acid metabolites. In
ddition, together with platelets, they can aggregate when
timulated, contribute to the plugging of microvessels, and
romote myocardial ischemia/infarction (6,7,21,24,32).
tudy limitations. This study was prospective in patient
nrollment and follow-up but was observational in nature
nd subject to limitations, including selection bias and
ncorrected confounding. A small proportion of incident
Is, i.e., those treated outside of the Intermountain Health
are system, might have been missed, leading to an under-
stimate of MI risk. A mechanistic explanation for our
ndings is not provided by our observational data and must
e explored separately. The study entailed an angiographic
opulation, and results might differ in some respects for
ther coronary-risk-prone populations; replication of these
esults in independent populations is encouraged. An asso-
iation does not prove causality; hence, a pathological role
or elevated WBC in CHD and acute coronary syndromes
as not been shown.
onclusions and implications. Total WBC count was
ound be an independent predictor of death/MI in a large,
rospectively followed cohort of patients with a high risk of
ncident coronary events, but greater predictive value was
rovided by high N (Q4 6.6  103/l) or low L counts.
ptimal risk prediction was given by the N/L ratio, with
4 versus Q1 (4.71 vs. 1.96) ratio, increasing hazard by
.2-fold. These findings provide important insights into
AD prognosis and pathogenesis using a routinely mea-
ured set of data. If validated, the finding of an abnormal
Q4) value for the WBC differential (e.g., N count or N/L
atio) might prompt more aggressive risk factor evaluation
nd therapy for patients with CAD, similar to the modifi-
ation of risk assessment and treatment currently recom-
ended for the finding of an elevated high-sensitivity CRP
alue (9).
eprint requests and correspondence: Dr. Jeffrey L. Anderson,
DS Hospital Cardiovascular Department, 8th Avenue and C
treet, Salt Lake City, Utah 84143. E-mail: jeffrey.anderson@
ocyte Ratio (Q4 vs. Q1) in Primary and
Hazard Ratio
(95% Confidence Interval) p Value
2.7 (2.1–3.6) 0.001
3.3 (1.8–5.9) 0.001
2.5 (1.9–3.4) 0.001
2.0 (1.7–2.5) 0.001
farction; Q  quartile.mph
l Nhc.com.
R1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
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